CFI-400945   Click here for help

GtoPdb Ligand ID: 8063

Synonyms: CFI 400945 | CFI400945
Compound class: Synthetic organic
Comment: CFI-400945 is first-in-class oral, and selective inhibitor of polo-like kinase 4 (PLK4) [1-2]. It has advanced to clinical evaluation in selected cancer patients.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 79.48
Molecular weight 534.26
XLogP 5.19
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES COc1ccc2c(c1)C1(CC1c1ccc3c(c1)[nH]nc3C=Cc1ccc(cc1)CN1CC(C)OC(C1)C)C(=O)N2
Isomeric SMILES COc1ccc2c(c1)[C@]1(CC1c1ccc3c(c1)[nH]nc3/C=C/c1ccc(cc1)CN1C[C@H](C)O[C@@H](C1)C)C(=O)N2
InChI InChI=1S/C33H34N4O3/c1-20-17-37(18-21(2)40-20)19-23-6-4-22(5-7-23)8-12-29-26-11-9-24(14-31(26)36-35-29)28-16-33(28)27-15-25(39-3)10-13-30(27)34-32(33)38/h4-15,20-21,28H,16-19H2,1-3H3,(H,34,38)(H,35,36)/b12-8+/t20-,21+,28?,33-/m0/s1
Bioactivity Comments
CFI-400945 significantly inhibits tumour growth in in vivo xenograft models [1].
Known off-targets include ABLT315I, TRKA, TRKB and BMX.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
polo like kinase 4 Primary target of this compound Hs Inhibitor Inhibition 8.6 pIC50 - 1
pIC50 8.6 (IC50 2.8x10-9 M) [1]